Ad is loading...
GLPG
Price
$26.73
Change
+$1.51 (+5.99%)
Updated
Nov 22, 03:22 PM (EDT)
82 days until earnings call
RXRX
Price
$5.80
Change
+$0.05 (+0.87%)
Updated
Nov 22, 03:36 PM (EDT)
102 days until earnings call
Ad is loading...

GLPG vs RXRX

Header iconGLPG vs RXRX Comparison
Open Charts GLPG vs RXRXBanner chart's image
Galapagos
Price$26.73
Change+$1.51 (+5.99%)
Volume$1.41K
CapitalizationN/A
Recursion Pharmaceuticals
Price$5.80
Change+$0.05 (+0.87%)
Volume$66.95K
CapitalizationN/A
GLPG vs RXRX Comparison Chart
Loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GLPG vs. RXRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a StrongBuy and RXRX is a StrongSell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (GLPG: $25.22 vs. RXRX: $5.75)
Brand notoriety: GLPG and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 133% vs. RXRX: 210%
Market capitalization -- GLPG: $1.73B vs. RXRX: $2.35B
GLPG [@Biotechnology] is valued at $1.73B. RXRX’s [@Biotechnology] market capitalization is $2.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than GLPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • GLPG’s TA Score: 4 bullish, 5 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than RXRX.

Price Growth

GLPG (@Biotechnology) experienced а -9.61% price change this week, while RXRX (@Biotechnology) price change was -16.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

GLPG is expected to report earnings on Feb 12, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.35B) has a higher market cap than GLPG($1.73B). GLPG YTD gains are higher at: -37.958 vs. RXRX (-41.684). GLPG has higher annual earnings (EBITDA): -63.34M vs. RXRX (-350.86M). GLPG has more cash in the bank: 3.34B vs. RXRX (428M). GLPG has less debt than RXRX: GLPG (11.5M) vs RXRX (90.6M). GLPG has higher revenues than RXRX: GLPG (260M) vs RXRX (64.6M).
GLPGRXRXGLPG / RXRX
Capitalization1.73B2.35B74%
EBITDA-63.34M-350.86M18%
Gain YTD-37.958-41.68491%
P/E Ratio53.70N/A-
Revenue260M64.6M402%
Total Cash3.34B428M780%
Total Debt11.5M90.6M13%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLPGRXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
63%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSSIX31.010.54
+1.77%
SouthernSun Small Cap, I
FIKGX93.271.58
+1.72%
Fidelity Advisor Semiconductors Z
KLGAX50.050.15
+0.30%
NYLI WMC Growth Class A
FAGAX176.770.48
+0.27%
Fidelity Advisor Growth Opps A
SIBAX35.820.06
+0.17%
Sit Balanced

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
-1.64%
VCYT - GLPG
43%
Loosely correlated
-0.66%
NTLA - GLPG
36%
Loosely correlated
+5.18%
AXON - GLPG
35%
Loosely correlated
+3.52%
RXRX - GLPG
35%
Loosely correlated
-4.80%
ABCL - GLPG
34%
Loosely correlated
+1.87%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-4.80%
BEAM - RXRX
62%
Loosely correlated
-3.72%
CRSP - RXRX
57%
Loosely correlated
-2.05%
PRME - RXRX
56%
Loosely correlated
-0.67%
EXAI - RXRX
56%
Loosely correlated
N/A
NTLA - RXRX
53%
Loosely correlated
+5.18%
More